ERAMET S.A.
ERAMET S.A. (ERMAY) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for ERAMET S.A. (ERMAY), covering cash flow, earnings, and balance sheets.
ERAMET S.A. (ERMAY) Income Statement & Financial Overview
Access detailed annual and quarterly income data for ERAMET S.A. ERMAY financial performance.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $1.48B | $1.49B | $1.65B | $855.00M |
| Cost of Revenue | $1.41B | $534.00M | $1.56B | $253.00M |
| Gross Profit | $74.00M | $957.00M | $83.00M | $602.00M |
| Gross Profit Ratio | $0.05 | $0.64 | $0.05 | $0.70 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $845.00M | $474.00M | $474.00M |
| Operating Expenses | -$46.00M | $1.002B | -$55.00M | $564.50M |
| Total Costs & Expenses | -$1.36B | $1.54B | $1.51B | $817.50M |
| Interest Income | $0.00 | $0.00 | $58.00M | $21.00M |
| Interest Expense | $50.00M | $68.00M | $0.00 | $0.00 |
| Depreciation & Amortization | $164.00M | $93.00M | $116.00M | $127.50M |
| EBITDA | $221.00M | $57.00M | $153.50M | $153.50M |
| EBITDA Ratio | $0.15 | $0.04 | $0.15 | $0.18 |
| Operating Income | $120.00M | -$45.00M | $138.00M | $26.00M |
| Operating Income Ratio | $0.08 | -$0.03 | $0.08 | $0.03 |
| Other Income/Expenses (Net) | -$113.00M | -$86.00M | $91.00M | $91.00M |
| Income Before Tax | $7.00M | -$131.00M | -$88.00M | $16.50M |
| Income Before Tax Ratio | $0.005 | -$0.09 | -$0.05 | $0.02 |
| Income Tax Expense | $33.00M | $61.00M | $73.00M | $36.50M |
| Net Income | $55.00M | -$41.00M | $11.00M | $9.50M |
| Net Income Ratio | $0.04 | -$0.03 | $0.007 | $0.01 |
| EPS | $1.92 | -$1.44 | $0.39 | $0.32 |
| Diluted EPS | $1.92 | -$1.44 | $0.37 | $0.33 |
| Weighted Avg Shares Outstanding | $28.58M | $28.47M | $28.49M | $29.92M |
| Weighted Avg Shares Outstanding (Diluted) | $28.60M | $28.47M | $30.04M | $29.06M |
Financial performance has remained strong, with revenue growing from $855.00M in Q3 2023 to $1.48B in Q4 2024. Gross profit continued to perform well, with margins at 5% in the latest quarter. Operating income reached $120.00M in Q4 2024, holding a steady 8% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $221.00M. Net income rose to $55.00M, keeping EPS at $1.92. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan